These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

988 related items for PubMed ID: 15110448

  • 1. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596
    [Abstract] [Full Text] [Related]

  • 3. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Jan 01; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

  • 4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 5. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan 15; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 15; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 7. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD.
    Clin Cancer Res; 2005 May 01; 11(9):3342-8. PubMed ID: 15867233
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy followed by late-course accelerated hyperfractionated radiation therapy for locally advanced non-small-cell lung cancer: long-term results of a phase I/II clinical trial.
    Chen M, Chen YY, Bao Y, Xian CG, Liu GZ, Zhang L, Xu GC, Deng XW, Lu TX, Qian JY, Cui NJ.
    Clin Lung Cancer; 2005 Mar 01; 6(5):304-9. PubMed ID: 15845182
    [Abstract] [Full Text] [Related]

  • 9. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
    Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS.
    Radiat Oncol Investig; 1999 Mar 01; 7(5):297-308. PubMed ID: 10580899
    [Abstract] [Full Text] [Related]

  • 10. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA, McGinnis WL, Stella PJ, Marschke RF, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA.
    Cancer; 1998 Mar 15; 82(6):1037-48. PubMed ID: 9506347
    [Abstract] [Full Text] [Related]

  • 11. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1397-404. PubMed ID: 19117690
    [Abstract] [Full Text] [Related]

  • 12. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    Marks LB, Garst J, Socinski MA, Sibley G, Blackstock AW, Herndon JE, Zhou S, Shafman T, Tisch A, Clough R, Yu X, Turrisi A, Anscher M, Crawford J, Rosenman J, Carolina Conformal Therapy Consortium.
    J Clin Oncol; 2004 Nov 01; 22(21):4329-40. PubMed ID: 15514374
    [Abstract] [Full Text] [Related]

  • 13. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Rojas AM, Lyn BE, Wilson EM, Williams FJ, Shah N, Dickson J, Saunders MI.
    Cancer; 2006 Sep 15; 107(6):1321-30. PubMed ID: 16902985
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 15; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 15. Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy.
    Thirion P, Holmberg O, Collins CD, O'Shea C, Moriarty M, Pomeroy M, O'Sullivan C, Buckney S, Armstrong J.
    Radiother Oncol; 2004 May 15; 71(2):163-6. PubMed ID: 15110449
    [Abstract] [Full Text] [Related]

  • 16. A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma.
    Viallet J, Brassard MA, Souhami L, Ayoub J, Del Vecchio P, Kreisman H, Guerra J, Gruber J, Langleben A, Hohneker J, Rousseau P.
    Cancer; 1999 Jun 15; 85(12):2562-9. PubMed ID: 10375103
    [Abstract] [Full Text] [Related]

  • 17. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 15; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 18. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3760-7. PubMed ID: 15837967
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 01; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 20. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):318-28. PubMed ID: 15667949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.